Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies
about
Piroxicam-β-cyclodextrin: a GI safer piroxicamSafe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksPatient benefit-risk in arthritis--a rheumatologist's perspective.Aspirin-exacerbated asthma.Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis.Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insightsProstaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway.Eupatilin Exerts Antinociceptive and Chondroprotective Properties in a Rat Model of Osteoarthritis by Downregulating Oxidative Damage and Catabolic Activity in ChondrocytesPrescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patientsRole of nitric oxide in the gastrointestinal tractChemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death.Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital.Myths and facts in the use of anti-inflammatory drugs.Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications.Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding.Gastrointestinal effects of aspirin.Acid-NSAID/aspirin interaction in peptic ulcer disease.Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice.Augmented chondroprotective effect of coadministration of celecoxib and rebamipide in the monosodium iodoacetate rat model of osteoarthritis.An Exploratory Study on the Anti-inflammatory Effects of Fucoidan in Relation to Quality of Life in Advanced Cancer Patients.Multimodal analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadol.Prevalence and predictors of non-steroidal anti-inflammatory drug/analgesic therapeutic duplication in the South Korean ambulatory care setting.Naringenin regulates production of matrix metalloproteinases in the knee-joint and primary cultured articular chondrocytes and alleviates pain in rat osteoarthritis model.Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice
P2860
Q27023475-D4AD76D6-5E0B-4B56-BAD8-AA681437050BQ30629677-9E5317C7-C5FC-4133-8FB4-12F461D28E37Q33803037-53D97205-1C97-420A-9AD0-DF42FBAF3E7DQ33846722-3D7612C8-7C9D-4C37-A536-D1367099A7DAQ33871754-C47747C5-9B59-49DF-AE80-5F97F89578DDQ34387174-CDB69065-700A-4E61-9DF2-E63A4534084DQ34663572-DFAFA1B1-51D6-4474-B22C-18B1B9839D05Q35311177-09929172-A8A6-4E89-A269-FEC927D65669Q35665907-41A72413-07AB-486E-8870-8B4452D6D352Q36011124-BCB6A66F-C191-4F36-BE36-F0D6D41A7224Q36972486-52C886CD-3947-420A-90DE-5905A5921B12Q37090409-B003A325-1393-4F08-B4D3-2B44D18BAE6CQ37415494-9A114F9F-19FA-40C9-82A1-A06D2F95C9B9Q37476911-9258CB6E-2352-48C5-AA91-BCC0EDAB9030Q37481108-3878C98B-D987-4674-9FFA-FCDE7097E809Q37778818-AF7C079B-296A-4420-9CA5-3790C6B1A51BQ37885723-634939D7-6959-49E4-81FF-25D9F0B5022FQ37957700-A3FE7849-8FB9-4DD3-A97D-DB1E754C05F6Q38439154-798B30A4-C7B6-4E06-87ED-B3BEEFC27797Q38454067-9267CA29-7ECC-4CCF-A532-937DED8C7211Q38669516-0EB0CD2D-DD8B-429E-8EB5-1CB26957DD36Q38741780-4EC695F1-DE65-44D2-A862-F07BB81CFFEDQ40405022-4759063D-E7C2-4DEF-BA9E-4A7C18428040Q42281869-670DDA5B-F2A6-4EAB-9731-D6A9469B8A69Q57072074-90654E07-140C-4713-87A8-37BD733D22B8
P2860
Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies
description
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2006)
@en
vedecký článok (publikovaný 2006)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd in 2006)
@nl
наукова стаття, опублікована у 2006
@uk
مقالة علمية (نشرت عام 2006)
@ar
name
Prevention of anti-inflammator ...... isks of therapeutic strategies
@ast
Prevention of anti-inflammator ...... isks of therapeutic strategies
@en
Prevention of anti-inflammator ...... isks of therapeutic strategies
@nl
type
label
Prevention of anti-inflammator ...... isks of therapeutic strategies
@ast
Prevention of anti-inflammator ...... isks of therapeutic strategies
@en
Prevention of anti-inflammator ...... isks of therapeutic strategies
@nl
prefLabel
Prevention of anti-inflammator ...... isks of therapeutic strategies
@ast
Prevention of anti-inflammator ...... isks of therapeutic strategies
@en
Prevention of anti-inflammator ...... isks of therapeutic strategies
@nl
P2860
P3181
P1433
P1476
Prevention of anti-inflammator ...... isks of therapeutic strategies
@en
P2093
Angel Lanas
Richard Hunt
P2860
P304
P3181
P356
10.1080/07853890600925843
P407
P577
2006-01-01T00:00:00Z